Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Saccades | 35 | 2016 | 244 | 6.010 |
Why?
|
Schizophrenia | 67 | 2023 | 6865 | 4.380 |
Why?
|
Psychomotor Performance | 25 | 2024 | 1895 | 2.790 |
Why?
|
Sleep | 25 | 2024 | 4619 | 2.290 |
Why?
|
Sleep Stages | 10 | 2023 | 685 | 2.170 |
Why?
|
Reaction Time | 32 | 2014 | 2091 | 1.940 |
Why?
|
Memory, Short-Term | 20 | 2022 | 976 | 1.870 |
Why?
|
Gyrus Cinguli | 10 | 2014 | 1091 | 1.710 |
Why?
|
Brain Mapping | 32 | 2024 | 6622 | 1.610 |
Why?
|
Schizophrenic Psychology | 19 | 2018 | 1671 | 1.370 |
Why?
|
Magnetoencephalography | 8 | 2014 | 624 | 1.320 |
Why?
|
Nerve Net | 15 | 2019 | 2173 | 1.300 |
Why?
|
Functional Laterality | 17 | 2018 | 2280 | 1.280 |
Why?
|
Cerebral Cortex | 13 | 2022 | 5692 | 1.170 |
Why?
|
Memory | 11 | 2024 | 2173 | 1.140 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2014 | 284 | 1.120 |
Why?
|
Polysomnography | 9 | 2022 | 1776 | 1.100 |
Why?
|
Attention | 13 | 2022 | 2393 | 1.020 |
Why?
|
Magnetic Resonance Imaging | 62 | 2024 | 35409 | 0.950 |
Why?
|
Electroencephalography | 20 | 2023 | 6061 | 0.920 |
Why?
|
Neural Pathways | 13 | 2022 | 2971 | 0.920 |
Why?
|
Prefrontal Cortex | 15 | 2016 | 2147 | 0.920 |
Why?
|
Brain | 34 | 2024 | 26345 | 0.910 |
Why?
|
Thalamus | 7 | 2022 | 1023 | 0.830 |
Why?
|
Photic Stimulation | 17 | 2013 | 2019 | 0.810 |
Why?
|
Brain Waves | 4 | 2019 | 401 | 0.800 |
Why?
|
Child Development Disorders, Pervasive | 4 | 2014 | 607 | 0.790 |
Why?
|
Mental Processes | 3 | 2016 | 247 | 0.780 |
Why?
|
Executive Function | 4 | 2016 | 1361 | 0.770 |
Why?
|
Frontal Lobe | 7 | 2016 | 1395 | 0.670 |
Why?
|
Pattern Recognition, Visual | 5 | 2012 | 824 | 0.660 |
Why?
|
Thalamic Nuclei | 1 | 2019 | 112 | 0.650 |
Why?
|
Body Dysmorphic Disorders | 1 | 2022 | 227 | 0.650 |
Why?
|
Dominance, Cerebral | 4 | 2007 | 626 | 0.630 |
Why?
|
Cognition Disorders | 11 | 2017 | 4041 | 0.560 |
Why?
|
Aquatic Organisms | 1 | 2016 | 46 | 0.550 |
Why?
|
Orientation | 3 | 2007 | 327 | 0.540 |
Why?
|
Birds | 1 | 2016 | 163 | 0.530 |
Why?
|
Learning | 5 | 2022 | 1710 | 0.520 |
Why?
|
Autistic Disorder | 6 | 2022 | 1162 | 0.510 |
Why?
|
Adult | 94 | 2024 | 213889 | 0.510 |
Why?
|
Neuropsychological Tests | 27 | 2017 | 6976 | 0.500 |
Why?
|
Endophenotypes | 2 | 2017 | 250 | 0.500 |
Why?
|
Feedback, Psychological | 3 | 2011 | 97 | 0.480 |
Why?
|
Visual Fields | 3 | 2014 | 1041 | 0.480 |
Why?
|
Cognition | 13 | 2023 | 6759 | 0.470 |
Why?
|
Video Games | 1 | 2016 | 184 | 0.450 |
Why?
|
Azabicyclo Compounds | 1 | 2013 | 68 | 0.450 |
Why?
|
Male | 101 | 2024 | 349776 | 0.440 |
Why?
|
Obsessive-Compulsive Disorder | 3 | 2018 | 1443 | 0.410 |
Why?
|
Humans | 132 | 2024 | 743811 | 0.400 |
Why?
|
Female | 97 | 2021 | 380020 | 0.390 |
Why?
|
Evoked Potentials | 2 | 2014 | 1022 | 0.380 |
Why?
|
Volition | 2 | 2010 | 63 | 0.380 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2018 | 2739 | 0.380 |
Why?
|
Mammals | 1 | 2016 | 1143 | 0.370 |
Why?
|
Hypnotics and Sedatives | 2 | 2020 | 1161 | 0.370 |
Why?
|
Catechol O-Methyltransferase | 2 | 2009 | 245 | 0.360 |
Why?
|
Intention | 1 | 2013 | 341 | 0.360 |
Why?
|
Image Processing, Computer-Assisted | 16 | 2017 | 8939 | 0.330 |
Why?
|
Asperger Syndrome | 3 | 2005 | 59 | 0.320 |
Why?
|
Cerebrum | 1 | 2010 | 137 | 0.320 |
Why?
|
Behavior | 1 | 2011 | 559 | 0.320 |
Why?
|
Motor Cortex | 2 | 2014 | 986 | 0.320 |
Why?
|
Stereotyped Behavior | 1 | 2008 | 136 | 0.310 |
Why?
|
Young Adult | 29 | 2023 | 56392 | 0.300 |
Why?
|
Memory Disorders | 6 | 2015 | 1186 | 0.300 |
Why?
|
Motor Skills | 3 | 2024 | 522 | 0.300 |
Why?
|
Neural Conduction | 1 | 2008 | 441 | 0.290 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1004 | 0.280 |
Why?
|
Fixation, Ocular | 1 | 2007 | 250 | 0.270 |
Why?
|
Thinking | 3 | 2016 | 317 | 0.270 |
Why?
|
Evoked Potentials, Motor | 2 | 2008 | 454 | 0.270 |
Why?
|
Perceptual Disorders | 1 | 2007 | 194 | 0.260 |
Why?
|
Form Perception | 2 | 2004 | 180 | 0.260 |
Why?
|
Middle Aged | 51 | 2019 | 213241 | 0.260 |
Why?
|
Motor Activity | 2 | 2018 | 2714 | 0.260 |
Why?
|
Social Perception | 3 | 2009 | 425 | 0.250 |
Why?
|
Analysis of Variance | 10 | 2014 | 6356 | 0.250 |
Why?
|
Hippocampus | 3 | 2024 | 3672 | 0.240 |
Why?
|
Mental Recall | 2 | 2015 | 1206 | 0.240 |
Why?
|
Wakefulness | 4 | 2022 | 1243 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 8 | 2022 | 17439 | 0.240 |
Why?
|
Choice Behavior | 2 | 2011 | 802 | 0.240 |
Why?
|
Face | 2 | 2007 | 993 | 0.240 |
Why?
|
Prosopagnosia | 1 | 2004 | 60 | 0.230 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2012 | 957 | 0.220 |
Why?
|
Parietal Lobe | 2 | 2010 | 832 | 0.220 |
Why?
|
Piperazines | 1 | 2013 | 2487 | 0.220 |
Why?
|
Dyslexia | 2 | 2022 | 239 | 0.210 |
Why?
|
Amygdala | 2 | 2009 | 1313 | 0.210 |
Why?
|
Reference Values | 6 | 2012 | 4974 | 0.210 |
Why?
|
Amnesia | 1 | 2024 | 248 | 0.200 |
Why?
|
Affective Symptoms | 1 | 2004 | 405 | 0.200 |
Why?
|
Antipsychotic Agents | 10 | 2017 | 3057 | 0.200 |
Why?
|
Visual Cortex | 2 | 2007 | 1136 | 0.200 |
Why?
|
Epilepsy, Rolandic | 1 | 2022 | 50 | 0.200 |
Why?
|
Visual Perception | 3 | 2018 | 1414 | 0.200 |
Why?
|
Occipital Lobe | 1 | 2022 | 377 | 0.190 |
Why?
|
Diazepam | 1 | 2021 | 205 | 0.190 |
Why?
|
Space Perception | 1 | 2004 | 474 | 0.190 |
Why?
|
Acoustic Stimulation | 2 | 2023 | 1209 | 0.190 |
Why?
|
Task Performance and Analysis | 6 | 2016 | 779 | 0.180 |
Why?
|
Models, Neurological | 5 | 2011 | 1771 | 0.180 |
Why?
|
Ataxia | 1 | 2022 | 304 | 0.180 |
Why?
|
Epilepsy, Generalized | 1 | 2022 | 174 | 0.180 |
Why?
|
Eye Movement Measurements | 2 | 2010 | 35 | 0.170 |
Why?
|
Leukoencephalopathies | 2 | 2012 | 238 | 0.170 |
Why?
|
Fingers | 2 | 2014 | 513 | 0.170 |
Why?
|
Social Behavior | 2 | 2005 | 1126 | 0.170 |
Why?
|
Cues | 5 | 2015 | 874 | 0.160 |
Why?
|
Case-Control Studies | 9 | 2019 | 21733 | 0.160 |
Why?
|
Adolescent | 23 | 2023 | 85729 | 0.160 |
Why?
|
Cross-Over Studies | 2 | 2020 | 2029 | 0.160 |
Why?
|
Alleles | 4 | 2014 | 6934 | 0.160 |
Why?
|
Neural Inhibition | 1 | 2002 | 598 | 0.160 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4326 | 0.150 |
Why?
|
Child | 13 | 2023 | 77637 | 0.150 |
Why?
|
Anisotropy | 3 | 2012 | 1263 | 0.150 |
Why?
|
DNA Methylation | 1 | 2011 | 4286 | 0.150 |
Why?
|
Basal Ganglia | 1 | 2000 | 546 | 0.150 |
Why?
|
Double-Blind Method | 5 | 2020 | 12020 | 0.150 |
Why?
|
Tetrahydrofolates | 1 | 2017 | 60 | 0.140 |
Why?
|
Epilepsies, Partial | 1 | 2021 | 435 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 2 | 2007 | 4033 | 0.140 |
Why?
|
Amobarbital | 1 | 1996 | 43 | 0.140 |
Why?
|
Rest | 3 | 2018 | 901 | 0.140 |
Why?
|
Dexmedetomidine | 1 | 2020 | 315 | 0.140 |
Why?
|
GABA Modulators | 1 | 1996 | 107 | 0.130 |
Why?
|
Anticipation, Psychological | 1 | 2016 | 87 | 0.130 |
Why?
|
Dopamine | 2 | 2016 | 1592 | 0.130 |
Why?
|
Regression Analysis | 3 | 2013 | 6457 | 0.130 |
Why?
|
Genotype | 5 | 2017 | 12944 | 0.130 |
Why?
|
Oxygen | 7 | 2013 | 4189 | 0.130 |
Why?
|
Psychiatric Status Rating Scales | 11 | 2017 | 6030 | 0.130 |
Why?
|
Models, Psychological | 2 | 2011 | 807 | 0.120 |
Why?
|
Receptors, Dopamine D1 | 1 | 2016 | 291 | 0.120 |
Why?
|
Ocular Motility Disorders | 2 | 2007 | 135 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2017 | 15518 | 0.120 |
Why?
|
Brain Diseases | 2 | 2021 | 1558 | 0.120 |
Why?
|
Neurogranin | 1 | 2013 | 15 | 0.120 |
Why?
|
Schizophrenic Language | 1 | 1994 | 69 | 0.120 |
Why?
|
Receptors, Dopamine D4 | 1 | 2014 | 171 | 0.120 |
Why?
|
Intelligence | 2 | 2016 | 920 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2012 | 3320 | 0.110 |
Why?
|
Time Factors | 6 | 2011 | 40038 | 0.110 |
Why?
|
Algorithms | 4 | 2010 | 13869 | 0.110 |
Why?
|
Cycloserine | 3 | 1999 | 112 | 0.110 |
Why?
|
Anxiety | 2 | 2024 | 4288 | 0.100 |
Why?
|
Discrimination Learning | 3 | 2005 | 280 | 0.090 |
Why?
|
Punishment | 1 | 2011 | 98 | 0.090 |
Why?
|
Electrooculography | 1 | 2010 | 116 | 0.090 |
Why?
|
Signal Transduction | 2 | 2016 | 23398 | 0.090 |
Why?
|
Verbal Learning | 1 | 2012 | 468 | 0.090 |
Why?
|
Temporal Lobe | 4 | 2012 | 1656 | 0.090 |
Why?
|
Neostriatum | 1 | 2011 | 249 | 0.090 |
Why?
|
Electrophysiological Phenomena | 1 | 2011 | 314 | 0.090 |
Why?
|
Kinesics | 1 | 2009 | 13 | 0.090 |
Why?
|
Reproducibility of Results | 7 | 2016 | 19894 | 0.080 |
Why?
|
Substantia Nigra | 1 | 2011 | 353 | 0.080 |
Why?
|
Corpus Striatum | 2 | 2016 | 1219 | 0.080 |
Why?
|
Knowledge | 1 | 2010 | 181 | 0.080 |
Why?
|
Genome-Wide Association Study | 4 | 2016 | 12259 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2002 | 2785 | 0.080 |
Why?
|
Expressed Emotion | 1 | 2009 | 92 | 0.080 |
Why?
|
Aging | 2 | 2018 | 8655 | 0.080 |
Why?
|
Severity of Illness Index | 6 | 2014 | 15526 | 0.080 |
Why?
|
Random Allocation | 2 | 2002 | 2429 | 0.080 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3655 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2021 | 3044 | 0.070 |
Why?
|
Emotions | 3 | 2024 | 2656 | 0.070 |
Why?
|
Psychomotor Disorders | 1 | 2007 | 152 | 0.070 |
Why?
|
Tobacco Use Disorder | 1 | 2012 | 688 | 0.070 |
Why?
|
Actigraphy | 1 | 2009 | 488 | 0.070 |
Why?
|
Social Behavior Disorders | 1 | 2005 | 97 | 0.070 |
Why?
|
Diffusion Tensor Imaging | 2 | 2012 | 2305 | 0.060 |
Why?
|
Information Dissemination | 1 | 2013 | 1099 | 0.060 |
Why?
|
Eye Movements | 1 | 2008 | 500 | 0.060 |
Why?
|
Reward | 1 | 2011 | 940 | 0.060 |
Why?
|
Magnetics | 2 | 2005 | 604 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 1951 | 0.060 |
Why?
|
Bipolar Disorder | 2 | 2019 | 5027 | 0.060 |
Why?
|
Principal Component Analysis | 3 | 2012 | 935 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2010 | 1001 | 0.060 |
Why?
|
Linear Models | 3 | 2016 | 5952 | 0.060 |
Why?
|
Animals | 4 | 2020 | 168660 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2009 | 2369 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2007 | 15067 | 0.050 |
Why?
|
Linguistics | 1 | 2022 | 98 | 0.050 |
Why?
|
Observer Variation | 2 | 2005 | 2592 | 0.050 |
Why?
|
Levodopa | 1 | 2002 | 221 | 0.050 |
Why?
|
Antiparkinson Agents | 1 | 2002 | 186 | 0.050 |
Why?
|
Motivation | 1 | 2011 | 1971 | 0.050 |
Why?
|
Neurophysiology | 1 | 2022 | 140 | 0.050 |
Why?
|
Language Development | 1 | 2022 | 186 | 0.050 |
Why?
|
Hemodynamics | 1 | 2011 | 4197 | 0.050 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2000 | 108 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12243 | 0.050 |
Why?
|
Facial Expression | 1 | 2004 | 508 | 0.050 |
Why?
|
Auditory Perception | 2 | 2018 | 566 | 0.050 |
Why?
|
Fear | 1 | 2009 | 1438 | 0.050 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1143 | 0.040 |
Why?
|
Schizotypal Personality Disorder | 1 | 2000 | 288 | 0.040 |
Why?
|
Probability Learning | 1 | 2018 | 23 | 0.040 |
Why?
|
Affective Disorders, Psychotic | 1 | 2019 | 191 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2004 | 2712 | 0.040 |
Why?
|
Developmental Disabilities | 1 | 2005 | 1452 | 0.040 |
Why?
|
Injections, Intra-Arterial | 1 | 1996 | 193 | 0.030 |
Why?
|
Kinetics | 1 | 2003 | 6476 | 0.030 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 1995 | 146 | 0.030 |
Why?
|
Time | 1 | 1997 | 542 | 0.030 |
Why?
|
Infant | 2 | 2023 | 35122 | 0.030 |
Why?
|
Smoking | 1 | 2012 | 8984 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2022 | 1937 | 0.030 |
Why?
|
Child, Preschool | 3 | 2023 | 40964 | 0.030 |
Why?
|
Biological Clocks | 1 | 2016 | 321 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2003 | 2732 | 0.030 |
Why?
|
Clozapine | 1 | 1996 | 498 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 3912 | 0.030 |
Why?
|
Concept Formation | 1 | 1994 | 158 | 0.030 |
Why?
|
New Mexico | 1 | 2012 | 86 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2014 | 454 | 0.030 |
Why?
|
Minnesota | 1 | 2012 | 344 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2014 | 501 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2883 | 0.030 |
Why?
|
Problem Solving | 1 | 1994 | 440 | 0.020 |
Why?
|
Syndrome | 1 | 1997 | 3249 | 0.020 |
Why?
|
Dreams | 1 | 1991 | 147 | 0.020 |
Why?
|
Folic Acid | 1 | 2017 | 1293 | 0.020 |
Why?
|
Paralysis | 1 | 1991 | 247 | 0.020 |
Why?
|
Models, Statistical | 1 | 2004 | 5100 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2009 | 229 | 0.020 |
Why?
|
Aged | 6 | 2019 | 163178 | 0.020 |
Why?
|
Cerebral Ventricles | 1 | 2012 | 542 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2014 | 1340 | 0.020 |
Why?
|
Seizures | 1 | 2022 | 2850 | 0.020 |
Why?
|
Hallucinations | 1 | 1991 | 358 | 0.020 |
Why?
|
Homozygote | 1 | 2013 | 1787 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14714 | 0.020 |
Why?
|
Sleep, REM | 1 | 1991 | 592 | 0.020 |
Why?
|
Corpus Callosum | 1 | 2012 | 736 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 3 | 1999 | 896 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1503 | 0.020 |
Why?
|
Brain Stem | 1 | 2012 | 844 | 0.020 |
Why?
|
Goals | 1 | 2011 | 708 | 0.020 |
Why?
|
Nonverbal Communication | 1 | 2005 | 63 | 0.020 |
Why?
|
Communication Disorders | 1 | 2005 | 51 | 0.020 |
Why?
|
Self Report | 1 | 2016 | 3550 | 0.020 |
Why?
|
Cerebellum | 1 | 2012 | 1487 | 0.020 |
Why?
|
Drug Administration Schedule | 3 | 1999 | 4931 | 0.020 |
Why?
|
Reading | 1 | 2008 | 554 | 0.020 |
Why?
|
Chronic Disease | 2 | 2009 | 9139 | 0.010 |
Why?
|
Fourier Analysis | 1 | 2004 | 446 | 0.010 |
Why?
|
Placebos | 2 | 1999 | 1674 | 0.010 |
Why?
|
Genetic Testing | 1 | 2016 | 3439 | 0.010 |
Why?
|
Drug Therapy, Combination | 3 | 1999 | 6487 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2703 | 0.010 |
Why?
|
Psychometrics | 1 | 2011 | 3000 | 0.010 |
Why?
|
Demography | 1 | 2007 | 1653 | 0.010 |
Why?
|
Amino Acids | 2 | 1999 | 1733 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 13980 | 0.010 |
Why?
|
Empathy | 1 | 2005 | 474 | 0.010 |
Why?
|
Sensory Thresholds | 1 | 2002 | 391 | 0.010 |
Why?
|
United States | 1 | 2008 | 69859 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2013 | 25032 | 0.010 |
Why?
|
Genetic Variation | 1 | 2016 | 6535 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7793 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6237 | 0.010 |
Why?
|
Cohort Studies | 2 | 2013 | 40545 | 0.010 |
Why?
|
Image Enhancement | 1 | 2010 | 2915 | 0.010 |
Why?
|
Treatment Outcome | 4 | 2017 | 63042 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 72252 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29777 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2004 | 1546 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2002 | 1760 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16361 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18355 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9582 | 0.010 |
Why?
|
Glycine | 1 | 1999 | 670 | 0.010 |
Why?
|
Movement | 1 | 2002 | 1471 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2008 | 7784 | 0.010 |
Why?
|
Nootropic Agents | 1 | 1995 | 160 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39001 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 1991 | 4266 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1996 | 10940 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13273 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 57744 | 0.010 |
Why?
|
Veterans | 1 | 2000 | 2519 | 0.000 |
Why?
|
Ambulatory Care | 1 | 1996 | 2707 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2013 | 77410 | 0.000 |
Why?
|